跳至主要内容
临床试验/NCT01570270
NCT01570270已完成1 期

Cheese Intake and Hypercholesterolemia

Azienda Ospedaliera Brotzu0 个研究点目标入组 42 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
42
主要终点
modification of LDL-cholesterol levels

研究概览

简要总结

In this study the investigators aimed at verifying whether consumption of a sheep cheese, naturally enriched in alpha-lipoic acid (ALA), conjugated linoleic acid (CLA) and vaccenic acid (VA), would modify the plasma lipid and endocannabinoid profiles in mild hypercholesterolemic subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 42 adult volunteers (19 male and 23 female) with diagnosed mild hypercholesterolemia (total cholesterol 220-290 mg/dL),
  • 30-60 years of age

排除标准

  • Pregnant (or those planning to become pregnant during the study period) and lactating women were excluded;
  • also individuals with a self-reported history of diabetes, inflammatory bowel disease, pancreatitis, gallbladder or biliary disease in the past 12 months, and lactose intolerance before the screening visit.
  • In addition, those with a history of cancer (except non-melanoma skin cancer) in the 2 years before screening, or of any major trauma or surgical event within 3 months before screening, were not enrolled.
  • Volunteers with the following characteristics were also excluded:
  • total cholesterol ≥ 300 mg/dL,
  • serum triglycerides ≥ 250 mg/dL or ≤ 200 mg/dL,
  • HDL ≥ 70mg/dL,
  • BMI ≥ 30, or
  • uncontrolled hypertension (systolic blood pressure ≥ 160 mm Hg or
  • diastolic blood pressure ≥ 100 mm Hg) at screening.

结局指标

主要结局

modification of LDL-cholesterol levels

时间窗: baseline and 3 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefano Pintus

Principal Investigator

Azienda Ospedaliera Brotzu

相似试验